Rick A. Bright an immunologist at the U.S. Centers for Disease Contro...Drugs belonging to this class like amantadine and rimantadine are in...The findings were reported in the Journal of the American Medical As...Statistics show that about 10-15% of the U.S. population suffers due...It was found that 91% of the 120 influenza a virus samples that ...
Rick A. Bright, an immunologist at the U.S. Centers for Disease Control and Prevention said that all samples of seasonal influenza virus this year have developed // resistance to adamantanes, the class of drugs which is used for the treatment for flu infection.
Drugs belonging to this class like amantadine and rimantadine are ineffectual for now and for the foreseeable future and shouldn't be used.
The findings were reported in the Journal of the American Medical Association. Amantadine and rimantadine were the pivotal drugs used against influenza A.
Statistics show that about 10-15% of the U.S. population suffers due to flu every year, and about 31,000 people die of it. Vaccination is considered the best strategy to prevent infection.
It was found that 91% of the 120 influenza a virus samples that were tested were resistant to these two drugs.
Presently a total of 209 influenza isolates (including the original 120) from 26 states across the United States were collected and analyzed. Overall resistance was found to be 92 %.
The researchers were very surprised at the speed with which the influenza strains develop the resistance. They feel that this is due to the widespread, over-the-counter and unregulated use of the drugs in other countries.
Tamiflu (oseltamivir) and Relenza (zanamivir) both the antiviral drugs belong to the neuraminidase inhibitor class of antivirals. The virus has not developed resistance against this class of drugs and hence can be used. But researchers fear that people will be using them more and might begin using them inappropriately and, with increased and inappropriate use, this will also become ineffective against the virus.
The researchers feel that there is an increased necessity for more energy and resources to be devoted to develop new antiviral drugs. In the end they conclude by saying that vaccines are the true way to protect oneself against influenz '"/>
(Date:11/27/2009)...v. 27 Team Garmin-Slipstream, the ... to ethical sporting and developing the next gener...t will become Team Garmin-Transitions with the add...he team. Transitions Optical is the world,s leadin...ost advanced photochromic technology in the widest...
(Date:11/27/2009)...les may reduce future disease burden, researchers ... -- Encouraging city dwellers to walk and bicycle ...lic health benefits than increased used of low-emi...The study compared the projected health effects in...s for London, England, and Delhi, India: business...
(Date:11/27/2009)...de; announced today that Spectrum Health (Grand Ra...ise orthopedic templating solution and its TraumaC... (PRWEB) November 27, 2009 -- Voyant Health&t...Rapids, Michigan) has licensed its TraumaCad Enter...aCad Extend workflow solution, to allow its orthop...
(Date:11/27/2009)...tive anatomy education apps from Modality and Lipp...es learning opportunities for iPhone and iPod touc...vember 27, 2009 -- Modality, Inc. and Lippincott...rs Kluwer Health, today announced the availability...ore. Clemente’s Anatomy, Rohen’s Photo...
(Date:11/26/2009)...cans living with diabetes will nearly double, incr...n 2034. Over the same period, spending on diabetes...336 billion, even with no increase in the prevalen... of Chicago report in the December issue of Diabe...overed by Medicare will rise from 8.2 million to 1...
...ielman, M.D, Duke University Medical Center to sho...ting HIV infections than those which charge a smal...he testing center and is therefore a very efficien...the testing centre were 4 per day but after the fr...
... Internet and e-mail contribute towards strengthen...is has been revealed by the Pew Internet and Ameri...social relations get affected as a result of the I... in those networks do not live close to them, a Pe...
...ndian Government to produce some films with the Na...ht the achievements of Indian Scientists, //in add... in science. The name of the new initiative of the...
The films will focus on nano-technology, the s...
...icist at the Max-Planck Institute for Dynamics and...which helped the researchers to understand the spr...s with the help of money trials.//
He tracked...scientist fight against easily transmissible disea...
... common cancer next to breast cancer in women and ...y recognisation of cervical cancer would help in e...tality due to cervical cancer. A cytologic screeni...above the age of 18 years require yearly Pap smear...
...tion (APA) has released tips to help prevent the b...ion during the National Heart Month.// Research ha...ess will have an adverse impact on their health an... in effective ways that don't at the same time tak...
(Date:11/25/2009)...Newswire/ -- BioTrends Research Group, Inc. releas... report, the first in a multi-phase syndicated mar...or Ortho-Biotech,s Stelara, from product launch th...wave of the report provides quantitative informati...nformation from a subset of 20. The reports asses...
(Date:11/25/2009)...v. 25 Regado Biosciences, a privat...rombotic aptamers with active control agents, anno...ll be presenting at the Piper Jaffray 21st Annual ...l in New York City. Dr. Mazzo,s presentation will...nd will include an overview of the Company,s pipel...
(Date:11/25/2009)... Nov. 25 Swissray International, I...graphy ( ddR ) systems, announced today that its o...vestor with a long term view towards growing Swiss...ded all assets and intellectual property, as well ...ess and growth Swissray is now poised to move to t...
...E PARK, N.C.--(BUSINESS WIRE)--Apr 3, 2007 -,Icage...ing a,planned meeting of the independent Data Moni...rial of senicapoc (formerly,ICA-17043) for the tre...ecommended that the trial be terminated because of...risis rate, the primary,endpoint. In making their ...
..., 2007--Treatment data from,Synovate Healthcare&rs...10,000 breast cancer patients in the UK could beco...lower death rates in,patients. The treatment was t...e edition of The Lancet (12 February 2007). Lower,...tched to the,aromotase inhibitor, Aromasin (exemes...
...c diagnostic instrument that measures the refracti...e using a Hartmann-Shack wavefront sensor. The mea...-cylindrical) refractive errors and irregularities...on in the human eye. The WaveScan software uses th...